Your browser does not support JavaScript!

Home    Search  

Results - Details

Search command : Author="Γανωτάκης"  And Author="Δημήτριος"  And Author="Φ."

Current Record: 3 of 5

Back to Results Previous page
Next page
Add to Basket
[Add to Basket]
Identifier 000397371
Title Μελέτη νέων αναλόγων του Gleevec στη λευχαιμική σειρά K562
Alternative Title A study of newly synthesised compounds based on Gleevec in K562 leukemic cell line
Author Μάρκου, Παναγιώτα Η.
Thesis advisor Τσιώτης, Γεώργιος
Reviewer Γανωτάκης, Δημήτριος Φ.
Περγαντής, Σπύρος Α.
Abstract Chronic Myelogenous Leukemia is a type of cancer which affects the hemopoiesis procedure. This malignancy is a result of a reciprocal translocation between chromosomes 9 and 22. The fusion of parts from these two chromosomes is a new chromosome called the Philadelphia Chromosome (Ph). This new chromosome encodes the p210BCR-ABL protein. This protein has a kinase domain, which is constitutively active, giving downstream signals for uncontrolled proliferation and cell growth. The research for the development of inhibitors for the kinase domain on p210BCR-ABL was essential. Gleevec, is the first drug that was released and was quite effective for inhibiting the activity of this protein. However, it is not a permanent cure since the leukemic cells have developed resistance mechanisms for this drug, making it no longer effective. This is causing the disease to progress rapidly to the final stage. New drugs are always a goal, resulting in the synthesis of new compounds. Those novel compounds were tested in vitro, on K562 cell line by the method of MTT and the IC50 values were calculated. Also, the compounds were tested for toxicity effects on white blood cells and red blood cells and for the induction of early apoptosis in K562 cells. In addition, proteome analysis of K562 cells, pre-incubated with the two novel compounds which had the lowest IC50 values and Gleevec, was conducted by Electrospray Tandem Mass Spectrometry coupled with Liquid Chromatography (nLC-ESI-MS / MS). In total, 2959 proteins were identified from which 684 were statistically significant and were found to be differentiated.
Language Greek
Subject Chronic Myelogenous Leukemia
Electrospray Tandem Mass Spectrometry Coupled with nano-Liquid Chromatography (nLC-ESI-MS/MS)
New Compounds
Philadelphia Chromosome (Ph)
Protein p210BCR-ABL
Tyrosine Kinase Inhibitors (TKIs)
Αναστολείς των Κινασών της Τυροσίνης (TKIs)
Διαδοχική Φασματομετρία Μάζας Ηλεκτροψεκασμού Συζευγμένη με Υγρή Χρωματογραφία (nLC-ESI-MS/MS)
Νέα Ανάλογα
Πρωτεΐνη p210BCR-ABL
Πρωτεομική Ανάλυση
Χρωμόσωμα Φιλαδέλφια (Ph)
Χρόνια Μυελογενής Λευχαιμία
Issue date 2015-11-20
Collection   School/Department--School of Sciences and Engineering--Department of Chemistry--Post-graduate theses
  Type of Work--Post-graduate theses
Permanent Link Bookmark and Share
Views 110

Digital Documents
No preview available

Download document
View document
Views : 13